Valuation: Rockwell Medical, Inc.

Market Cap 24.18M 21.13M 19.5M 17.97M 33.87M 2.33B 34.62M 233M 91.65M 1.14B 90.79M 88.8M 3.93B P/E 2026 *
-6.96x
P/E 2027 * -72.1x
Enterprise Value 24.18M 21.13M 19.5M 17.97M 33.87M 2.33B 34.62M 233M 91.65M 1.14B 90.79M 88.8M 3.93B EV / Sales 2026 *
0.33x
EV / Sales 2027 * 0.31x
Free-Float
84.88%
Yield 2026 *
-
Yield 2027 * -
1 day+6.89%
1 week+9.18%
Current month+11.26%
1 month-4.30%
3 months-32.96%
6 months-36.02%
Current year-26.51%
1 week 5.5
Extreme 5.505
6.19
1 month 4.88
Extreme 4.885
7
Current year 4.88
Extreme 4.885
12.9
1 year 4.88
Extreme 4.885
21
3 years 4.88
Extreme 4.885
51.5
5 years 4.88
Extreme 4.885
89.1
10 years 4.88
Extreme 4.885
987.8
Manager TitleAgeSince
Chief Executive Officer 73 01/07/2022
Director of Finance/CFO 48 12/12/2024
Chief Operating Officer 47 23/09/2025
Director TitleAgeSince
Director/Board Member 67 07/09/2017
Director/Board Member 79 11/06/2020
Director/Board Member 73 01/07/2022
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Free

Executive/Senior Manager

15,000 0.0380%
01/07/26 Free

Director

9,633 0.0244%
01/07/26 Free

Director

9,633 0.0244%
Change 5-day change 1-year change 3-year change Capi.($)
+6.89%+9.18%-44.32%-84.76% 24.18M
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average +0.63%+1.40%+21.25%+40.04% 357.51B
Weighted average by Cap. +0.37%+0.02%+37.51%+79.63%

Financials

2026 *2027 *
Net sales 72.47M 63.33M 58.44M 53.87M 102M 6.98B 104M 699M 275M 3.42B 272M 266M 11.77B 78.29M 68.42M 63.13M 58.19M 110M 7.54B 112M 755M 297M 3.69B 294M 288M 12.71B
Net income -3.52M -3.08M -2.84M -2.62M -4.94M -339M -5.05M -33.98M -13.36M -166M -13.24M -12.95M -572M -296K -259K -239K -220K -415K -28.51M -424K -2.85M -1.12M -13.96M -1.11M -1.09M -48.06M
Net Debt - -
Logo Rockwell Medical, Inc.
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.
Employees
157
Date Price Change Volume
17/07/26 $6.125 +6.89% 101,106
16/07/26 $5.730 +1.60% 14,200
15/07/26 $5.640 +0.18% 7,693
14/07/26 $5.630 -0.71% 11,389
13/07/26 $5.670 +1.07% 28,399
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.125USD
Average target price
30.00USD
Spread / Average Target
+389.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RMTI Stock